NovaBridge Biosciences Charity Care, Reimbursements Received
NovaBridge Biosciences (NBP) reported Charity Care, Reimbursements Received of CNY 5.35 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Notes
us-gaap:CharityCareReimbursementsReceived · last filed 2024-04-30
- NovaBridge Biosciences charity care, reimbursements received for the quarter ending 2020-12-31 was 975.00K CNY, a 151.29% increase year-over-year.
- NovaBridge Biosciences charity care, reimbursements received for the quarter ending 2019-12-31 was 388.00K CNY.
CNY
| Period end | Charity Care, Reimbursements Received 3 month | Charity Care, Reimbursements Received 6 month | Charity Care, Reimbursements Received 9 month | Charity Care, Reimbursements Received 12 month |
|---|---|---|---|---|
| 2023-12-31 | 5.35M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 25.47M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 12.35M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 9.22M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 3.76M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 975.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 11.63M CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 10.66M CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 388.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 568.00K CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 180.00K CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 750.00K CNY 20-F · filed 2021-04-28 |
USD
| Period end | Charity Care, Reimbursements Received 3 month | Charity Care, Reimbursements Received 6 month | Charity Care, Reimbursements Received 9 month | Charity Care, Reimbursements Received 12 month |
|---|---|---|---|---|
| 2023-12-31 | $754.00K 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $3.69M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $1.84M 6-K · filed 2022-11-10 | |||
| 2021-12-31 | $1.45M 20-F · filed 2022-04-29 | |||
| 2020-12-31 | $213.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $1.78M 20-F · filed 2021-04-28 | ||
| 2020-09-30 | $1.57M 6-K · filed 2021-02-05 | |||
| 2019-12-31 | $82.00K 20-F · filed 2020-04-29 |